• Key Author discovering MECO's lead asset - a diagnostic tool and predictive biomarker test. Continue to prepare company strategic messaging, such as pitch deck creation and investor relations liaison.
• Introduced and continue to liaise key relationships within the commercial diagnostics industry
• i.e., introduced and continue to liaise with critical Outsourced Contract Development Partner enabling the launch of their primary revenue stream.
• Expert scientific oversight translating a unique scientific discovery into a viable commercial opportunity.

SMART is the Subject Matter Advisory Resource Team made up of subject matter experts that support NEMIC and its community of startups by providing advice, insight, knowledge, and connections to ultimately advance medical technologies to market. Handpicked as a top subject matter expert and known to support the cultivation of an accessible and supportive MedTech entrepreneurial ecosystem in Rhode Island.

● Recognized closer for $40M of contracted business, delivering a technical subject matter perspective to better align our development strategy with the client goals.
● Commercialized over 24 cutting-edge medical products across all sectors of the business (Medtech, diagnostics, drug delivery and cell therapies) as Tactical Product Development leader
● Led the evolution of the corporate Research & Development capabilities beyond industry standards making it possible to partner with our clients at the deepest levels of innovation and discovery in the healthcare space.
● Featured speaker at world renowned Venture Café event showcasing the complexities of technology development in the post-COVID healthcare industry.

• Generated $2M in new business by fostering strategic relationships with academic institutions to leverage their biotechnology capabilities and recruit a new pipeline of clients requiring development services.
• Developed from scratch the new revenue stream for the firm that was the key to the firm being attractive to buyers and ultimately purchased. i.e., From scratch, grew the Research & Development Engineering team to 12 that developed 3 "FDA breakthrough" designated technologies (of 36+ designed products), hence service line, hence revenue stream.
• Prepared and presented technical case studies on my process and product development experience at strategic scientific and industry conferences (Ex. COMSOL DAY 2019).

• Senior lead consultant on client product development teams, specializing in early phase discovery and innovation challenges.
• Technical Subject Matter Expert enhancing the clinical performance of at least a dozen novel medical products in development.
• Led strategic initiatives to successfully install novel Biosafety Level II and Level I laboratories within existing manufacturing facilities.

Lab of Jon Reichner, Ph.D.
● Longitudinal clinical research of septic/trauma patient neutrophil response and regulation

Lab of Christian Franck, Ph.D
● Provided executive leadership of preclinical collaborative cell biomechanics study managing 30 personnel between immunology, pathobiology, and experimental soft matter mechanics laboratories
● Authored several peer-reviewed publications, including Cell Reports article discovering role of mechanical memory in breast cancer metastasis, leading to the formation of MECO Diagnostics

• Led and coordinated recruitment, training, and mentorship for team of interdepartmental faculty and students, also lab purchasing, biosafety regulation, protocol management, project and workflow development.

• Achieved 2014 Arizona TRIF Imaging Fellowship and Galileo Circle Outstanding Scholar Award receiving $100,000 in research funding
• Engineered complex and physiologically accurate in vitro polymeric micro-environments facilitating cutting-edge high-speed and long-scale observation of native versus tumorigenic cellular invasive capacities.

Center for Cell Analysis and Modeling, Laboratory of Charles Wolgemuth, Ph.D
• Innovated and developed novel quantitative live imaging assays validating theoretical biophysical modeling predictions of bacterial motility, single cell invasion and collective migration dynamics.